Epidemiology and Outcomes

Exploring lifetime occupational exposure and SLE flare: a patient-focussed pilot study
Marline L Squance, Maya Guest, Glenn Reeves, John Attia, Howard Bridgman

Lupus Science & Medicine May 2014, 1 (1) e000023; DOI: 10.1136/lupus-2014-000023
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
Richard Furie, Michelle A Petri, Vibeke Strand, Dafna D Gladman, Z John Zhong, William W Freimuth, the BLISS-52 and BLISS-76 Study Groups

Lupus Science & Medicine Jun 2014, 1 (1) e000031; DOI: 10.1136/lupus-2014-000031
Which outcome measures in SLE clinical trials best reflect medical judgment?
Aikaterini Thanou, Eliza Chakravarty, Judith A James, Joan T Merrill

Lupus Science & Medicine Apr 2014, 1 (1) e000005; DOI: 10.1136/lupus-2013-000005
Causes and outcome of hospitalisations in Tunisian patients with systemic lupus erythematosus
M Jallouli, H Hriz, Y Cherif, S Marzouk, M Snoussi, F Frikha, R Ben Salah, H Masmoudi, Z Bahloul

Lupus Science & Medicine May 2014, 1 (1) e000017; DOI: 10.1136/lupus-2014-000017
Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study
M Scolnik, J Marin, S M Valeiras, M F Marchese, A S Talani, N L Avellaneda, A Etchepare, P Etchepare, M S Plou, E R Soriano

Lupus Science & Medicine May 2014, 1 (1) e000021; DOI: 10.1136/lupus-2014-000021
Unique clinical characteristics, autoantibodies and medication use in Native American patients with systemic lupus erythematosus
Joseph M Kheir, Carla J Guthridge, Jonathon R Johnston, Lucas J Adams, Astrid Rasmussen, Timothy F Gross, Melissa E Munroe, Rebecka L Bourn, Kathy L Sivils, Joel M Guthridge, Michael H Weisman, Daniel J Wallace, Juan-Manuel Anaya, Adriana Rojas Villarraga, James N Jarvis, John B Harley, Judith A James

Lupus Science & Medicine Feb 2018, 5 (1) e000247; DOI: 10.1136/lupus-2017-000247
Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort
Chiara Tani, Roberta Vagelli, Chiara Stagnaro, Linda Carli, Marta Mosca

Lupus Science & Medicine Feb 2018, 5 (1) e000234; DOI: 10.1136/lupus-2017-000234
Presentation of SLE in UK primary care using the Clinical Practice Research Datalink
Alison L Nightingale, Julie E Davidson, Charles T Molta, Hong J Kan, Neil J McHugh

Lupus Science & Medicine Feb 2017, 4 (1) e000172; DOI: 10.1136/lupus-2016-000172
Predictors of incident proteinuria among patients with SLE
Alí Duarte-García, Erik Barr, Laurence S Magder, Michelle Petri

Lupus Science & Medicine May 2017, 4 (1) e000200; DOI: 10.1136/lupus-2016-000200
Clinicians approaches to management of background treatment in patients with SLE in clinical remission: results of an international observational survey
Pintip Ngamjanyaporn, Eoghan M McCarthy, Jamie C Sergeant, John Reynolds, Sarah Skeoch, Benjamin Parker, Ian N Bruce

Lupus Science & Medicine Jun 2017, 4 (1) e000173; DOI: 10.1136/lupus-2016-000173

Main menu

Epidemiology and Outcomes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Epidemiology and Outcomes

Pages